UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9168) 9168
Newsletter (76) 76
Book Chapter (28) 28
Newspaper Article (24) 24
Magazine Article (21) 21
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8695) 8695
science & technology (6472) 6472
life sciences & biomedicine (6339) 6339
male (5632) 5632
female (5345) 5345
interferon-alpha - therapeutic use (4965) 4965
interferon-alpha - adverse effects (4941) 4941
middle aged (4894) 4894
adult (4350) 4350
recombinant proteins (3551) 3551
hepatitis c, chronic - drug therapy (2968) 2968
antiviral agents - therapeutic use (2949) 2949
interferon-alpha - administration & dosage (2885) 2885
treatment outcome (2554) 2554
antiviral agents - adverse effects (2545) 2545
aged (2511) 2511
drug therapy, combination (2420) 2420
ribavirin - therapeutic use (2075) 2075
interferon (1963) 1963
gastroenterology & hepatology (1913) 1913
hepatitis c (1791) 1791
polyethylene glycols - therapeutic use (1632) 1632
ribavirin - adverse effects (1454) 1454
antiviral agents - administration & dosage (1319) 1319
hepacivirus - genetics (1196) 1196
polyethylene glycols - adverse effects (1187) 1187
ribavirin (1175) 1175
oncology (1155) 1155
biological response modifiers (1128) 1128
ribavirin - administration & dosage (1098) 1098
hepatitis c - drug therapy (1070) 1070
hepatitis c virus (1017) 1017
genotype (1015) 1015
recombinant proteins - therapeutic use (1005) 1005
interferon alpha (994) 994
interferon alpha-2 (901) 901
abridged index medicus (895) 895
care and treatment (895) 895
polyethylene glycols - administration & dosage (816) 816
health aspects (793) 793
adolescent (767) 767
drug administration schedule (755) 755
drug therapy (755) 755
antineoplastic combined chemotherapy protocols - therapeutic use (754) 754
hepatitis c, chronic - virology (753) 753
prospective studies (728) 728
time factors (716) 716
hepatitis (706) 706
pharmacology & pharmacy (681) 681
recombinant proteins - adverse effects (662) 662
follow-up studies (659) 659
infectious diseases (656) 656
viral load (651) 651
hepacivirus - drug effects (649) 649
dose-response relationship, drug (598) 598
rna, viral - blood (594) 594
immunology (584) 584
hepatitis c, chronic - complications (581) 581
general & internal medicine (575) 575
risk factors (574) 574
retrospective studies (564) 564
medicine, general & internal (561) 561
recombinant proteins - administration & dosage (555) 555
antineoplastic combined chemotherapy protocols - adverse effects (527) 527
antineoplastic agents - therapeutic use (525) 525
antineoplastic agents - adverse effects (514) 514
young adult (505) 505
medicine & public health (488) 488
recurrence (475) 475
virology (466) 466
analysis (461) 461
hematology (460) 460
chronic hepatitis c (450) 450
animals (440) 440
polyethylene glycols (430) 430
melanoma - drug therapy (402) 402
research (399) 399
hepatitis b, chronic - drug therapy (397) 397
combined modality therapy (383) 383
prognosis (366) 366
aged, 80 and over (365) 365
gastroenterology and hepatology (361) 361
interferon-alpha - pharmacology (360) 360
hepatitis c - complications (356) 356
interferon-alpha (353) 353
genetic aspects (339) 339
virus diseases (336) 336
antiviral agents (333) 333
dermatology (325) 325
injections, subcutaneous (320) 320
clinical trials (318) 318
internal medicine (317) 317
hepacivirus - isolation & purification (310) 310
survival rate (310) 310
cancer (308) 308
hepatitis c - therapy (306) 306
child (302) 302
immunotherapy (302) 302
infections (298) 298
disease progression (285) 285
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8606) 8606
French (189) 189
German (185) 185
Japanese (164) 164
Spanish (137) 137
Chinese (61) 61
Portuguese (50) 50
Russian (45) 45
Polish (34) 34
Italian (26) 26
Hungarian (18) 18
Korean (13) 13
Czech (11) 11
Dutch (8) 8
Danish (7) 7
Serbian (6) 6
Slovak (6) 6
Croatian (5) 5
Norwegian (4) 4
Swedish (4) 4
Turkish (4) 4
Hebrew (3) 3
Bulgarian (2) 2
Romanian (2) 2
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 11/2011, Volume 103, Issue 21, pp. 1572 - 1587
..., interleukin-2, ipilimumab, tremelimumab, thalidomide, and lenalidomide. Primary hypothyroidism is the most common side effect, although thyrotoxicosis and effects on thyroid... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Hypothyroidism - chemically induced | Thyroid Function Tests | Hyperthyroidism - diagnosis | Interleukin-2 - adverse effects | Recombinant Fusion Proteins - adverse effects | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Antineoplastic Agents - administration & dosage | Recombinant Proteins - adverse effects | Tetrahydronaphthalenes - adverse effects | Hyperthyroidism - chemically induced | Thalidomide - analogs & derivatives | Antineoplastic Agents - adverse effects | Diphtheria Toxin - adverse effects | Thyroid Hormones - blood | Anticarcinogenic Agents - adverse effects | Interleukin-2 - analogs & derivatives | Thyroiditis, Autoimmune - chemically induced | Molecular Targeted Therapy - methods | Thyroid Gland - drug effects | Thalidomide - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Hyperthyroidism - blood | Radioimmunotherapy | Hypopituitarism - etiology | Hypothyroidism - diagnosis | Alemtuzumab | Hypothyroidism - etiology | Neoplasms - drug therapy | Iodine Radioisotopes - administration & dosage | Hypopituitarism - complications | Neoplasms - immunology | Hypothyroidism - drug therapy | Quality of Life | Interferon-alpha - adverse effects | Hypothyroidism - blood | Thyroid Gland - metabolism | Antibodies, Neoplasm - adverse effects | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Complications and side effects | Usage | Thyroid diseases | Diagnosis | Antineoplastic agents | Thyroid gland function tests | Risk factors | Hypothyroidism | Medical diagnosis | Medical treatment | Index Medicus | Review
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2013, Volume 368, Issue 1, pp. 34 - 44
Journal Article
Pharmacotherapy, ISSN 0277-0008, 05/2020, Volume 40, Issue 5, pp. 416 - 437
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19)... 
dialysis | renal | antivirals | cytochrome P450 | infectious disease | liver | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pandemics | Alanine - adverse effects | Adrenal Cortex Hormones | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Thiazoles - administration & dosage | Hydroxychloroquine - adverse effects | Thiazoles - adverse effects | Alanine - analogs & derivatives | Alanine - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Ritonavir - adverse effects | Ribavirin - administration & dosage | Betacoronavirus | Antibodies, Monoclonal, Humanized - adverse effects | Ritonavir - administration & dosage | Immunomodulation | Azetidines - adverse effects | Chloroquine - adverse effects | Antiviral Agents - administration & dosage | Adenosine Monophosphate - adverse effects | Hydroxychloroquine - administration & dosage | Nelfinavir - adverse effects | Interferon-alpha - administration & dosage | Azetidines - administration & dosage | Ribavirin - adverse effects | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Antiviral Agents - adverse effects | Coronavirus Infections - therapy | Immunization, Passive | Lopinavir - administration & dosage | Sulfonamides - adverse effects | Chloroquine - administration & dosage | Interferon-alpha - adverse effects | Nelfinavir - administration & dosage | Drug Combinations | Lopinavir - adverse effects | Sulfonamides - administration & dosage | Severe acute respiratory syndrome coronavirus 2 | COVID-19 | Antiviral agents | Therapeutic applications | Clinical trials | Coronaviruses | Drug therapy | Patients | Index Medicus | Reviews of Therapeutics | Review of Therapeutics
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 05/2014, Volume 73, Issue 5, pp. 831 - 837
Journal Article
Blood, ISSN 1528-0020, 07/2015, Volume 126, Issue 1, pp. 42 - 49
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2013, Volume 145, Issue 5, pp. 1035 - 1044.e5
Journal Article